Laxmi Dental Ltd Q3 FY26 – ₹66 Cr Revenue, 69.5% Gross Margin… But Profit Cracked Under Tariff Pressure – Digital Dentistry Story or Margin Illusion?
1. At a Glance – The Dentist Who Charges Premium but Gives You Pain Later
Welcome to the most interesting IPO baby of 2025 — a company that literally deals with teeth, but investors right now are the ones grinding theirs.
Laxmi Dental is not your average “clinic wala dental business.” This is a full-stack, globally exporting, digitally ambitious, margin-sensitive, tariff-hit, ESOP-heavy, acquisition-loving, scanner-selling beast trying to become the Infosys of dentistry… but currently behaving like a startup stuck between ambition and execution.
Revenue is growing. Margins? Getting punched by US tariffs. Profit? Distorted by accounting changes. Management? Optimistic like every Indian promoter after a tough quarter.
And the stock? Down ~57% in one year. Yes, your portfolio probably needs a root canal.
But here’s the twist — behind all the chaos lies a genuinely interesting business:
India’s only end-to-end dental ecosystem
Exports to 95+ countries
Strong push toward digital dentistry (scanners + AI + aligners)
Backed by global investors like OrbiMed and Goldman Sachs
So what is this company?
A future global dental tech player?
Or a fancy lab business struggling to scale profitably?
Let’s open the mouth and check every cavity.
2. Introduction – IPO Glamour Meets Reality Check
Laxmi Dental listed in Jan 2025 with all the ingredients investors love:
Healthcare + exports = sexy
Digital + AI + aligners = even sexier
High ROE + growth = jackpot
And then… reality happened.
Q3 FY26 came in with:
Revenue growth → okay (+7%)
EBITDA → compressed
PAT → crushed
Exceptional charges → added masala
Tariffs → global geopolitics enters your dental chair
Management basically said:
“Business is fine… duniya kharab hai.”
Classic.
But if you read between the lines (and we will), something deeper is happening:
The company is transitioning from traditional lab to digital dentistry platform
That transition is hurting margins temporarily
And investors? They expected smooth compounding, not volatility
Now the real question:
👉 Are you holding a future leader during its ugly phase? 👉 Or a company that peaked too early post IPO?
3. Business Model – WTF Do They Even Do?
Let’s simplify this without using MBA jargon.
Laxmi Dental runs a multi-layered dental empire:
1. Laboratory Business (Old School Cash Cow)
Crowns, bridges, dentures
Custom-made dental products
Large export base (especially US)
This is the bread-and-butter.
2. Aligner Solutions (New Age Growth Story)
Clear aligners (like Invisalign type)
Brands: Illusion, Bizdent, Taglus
This is where growth + margins should come from.
3. Digital Dentistry (Scanner + AI Game)
Intraoral scanners
AI dent platforms
Digital workflows
This is the future… but also margin dilution currently.
4. Pediatric Products (Small but High Potential)
Kids dental products (Kids-E-Dental)
Waiting for regulatory triggers (CE certification).
So essentially:
👉 They are trying to become “Apple + TCS + Colgate” of dentistry 👉 But right now behaving like a confused startup with too many ideas
Let me ask you:
Do you like focused businesses… or ambitious chaos?
4. Financials Overview – Growth Hai… But Profit Ka Kya?
